Analysis of the gene expression of CD4+ T lymphocytes activated with potentised sulphur from patients with periodontal inflammation and a healthy control group
An in vitro - ex vivo study.
Project overview
Periodontitis is an inflammatory disease of the gums and periodontium that leads to tooth loss if left untreated. Every second adult suffers from a moderate form of periodontitis, every tenth adult suffers from a severe form. From an immunological point of view, certain leukocyte subpopulations are found at the site of the inflammatory reaction.
In our preliminary work on basic research projects with potentised substances in 2010 and 2015, activated CD4+ T lymphocytes and granulocytes from periodontitis blood donors have already been observed. In particular, a specific immunomodulatory effect of potentised sulphur on human cells can be assumed. Other experts in the field of basic research on homeopathy have also already taken up gene expression models. However, little is known about the gene expression of homeopathically stimulated immunomodulating human cells in a periodontitis donor group compared to a healthy control group.
Further information
- Responsible: Chair of Medical Theory, Integrative and Anthroposophic Medicine
- Funding: Software AG - Foundation
- Cooperation partners:
Prof. Dr Thomas Dittmar, Chair and Institute of Immunology (Scientific Director)
Prof. Dr med. dent. Anton Friedmann, Chair of Periodontology (Dental Director)
Prof. Dr Thomas Ostermann, Chair of Research Methodology and Statistics in Psychology (Biometry and Statistics)
Goals and methods
A molecular biology approach is used to investigate CD+4 T lymphocytes and their gene expression under sulphur stimulation in periodontitis. Sulphur D12 will be tested for a number of genes involved in immune modulation in inflammation. In this monocentric, prospective, two-arm controlled in-vitro matched-pairs study, gene expression profiles of isolated CD 4+ T lymphocytes from whole blood will be generated after stimulation with Sulphur D12 from 25 periodontitis patients and 25 healthy volunteers. The study will start in spring 2025.
Discourse
With these in-vitro and ex-vivo experiments, we aim to open up an outlook and a perspective. Addressing the question of the mechanisms of action of potentised substances on human cells and the transferability of the results into clinical practice is in the spirit of translational research.
Project management
Dr rer. medic.
Christa Kunigunde Raak
Researcher
Faculty of Health (School of Medicine) | Chair of Medical Theory, Integrative and Anthroposophic Medicine
- +49 2330 62-3643
Orcid ID: 0000-0002-8056-6869
Gerhard-Kienle-Weg 4
58313 HerdeckeRoom number: Haus D, DG